Delivery Order SPE2DB20D3103-SPE2DB25FQ2M1
- Not listed
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.61 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $8,697.19 under a firm fixed price arrangement. This non-set-aside delivery order, issued on August 12, 2025, with completion scheduled for August 13, 2025, will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a $33,272.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-unit packaging) with a completion date of July 22, 2025. This non-set-aside competitive award was issued on July 21, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's ongoing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $6,795.56 to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV treatment and prevention. The contract was competitively awarded without set-aside provisions and is classified as firm fixed price, with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $19,179.38. This non-competitive delivery order is expected to be completed by July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the federal government's ongoing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,954.30 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order valued at $5,795.72 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV treatment medication combining emtricitabine and tenofovir alafenamide,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2M1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $65,557.87 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, supporting the federal government's pharmaceutical supply chain for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, consistently demonstrates capability to fulfill federal medical procurement requirements through open competition and serves critical federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.6k | 9/10/25 |